Conviction
$ Value
$15.0M
Shares
588,235
Price
$26
Filed
Sep 8
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $5.0M (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
AKKARAJU SRINIVAS
Title
—
CIK
0001253170
Roles
Transaction Details
Transaction Date
2025-09-04
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
588,235
Footnotes
Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opp LP"). Samsara Opportunity Fund GP, LLC ("Samsara Opp GP") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. | Securities are directly held by Samsara BioCapital L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
Filing Info
AKKARAJU SRINIVAS's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-09 | ALMS | ▲ | $10.0M |
| 2025-12-22 | KLRS | A | $15.0M |
| 2025-12-12 | SRRK | X | $7.8M |
| 2025-12-12 | SRRK | X | $0 |
| 2025-12-05 | ALMS | ▲ | $581K |
| 2025-12-05 | ALMS | ▲ | $701K |
| 2025-12-05 | ALMS | ▲ | $551K |
| 2025-12-04 | ALMS | ▲ | $540K |
| 2025-12-03 | ALMS | ▲ | $775K |
| 2025-12-02 | ALMS | ▲ | $725K |
Other Insiders at MLYS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $8.8M | — | 2026-03-30 |
|
Congleton Jon
Chief Executive Officer
|
— | $2.4M | 2026-04-13 |
|
Rodman David Malcom
Chief Medical Officer
|
— | $621K | 2026-04-17 |
| Karydas Daphne | — | $75K | 2026-03-31 |